President Donald Trump speaks speaks on the latest developments of the coronavirus outbreak, while flanked by White House coronavirus response coordinator Debbie Birx (L), and U.S. Surgeon General Jerome Adams (R), in the James Brady Press Briefing Room at the White House March 19, 2020. (Photo by Chip Somodevilla/Getty Images)
President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases.
The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.
"We're going to be able to make that drug available almost immediately," Trump said.
The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.
He also tempered the president's optimism about the still-untested solution.
"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."
New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.
"The therapies are something we could move on much faster potentially," Trump said.
He claimed the administration "slashed red tape" to develop new vaccines and therapies.
The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks.
"If we find that we need something, then we will do that," he said.
Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak.
The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.
"We continue our relentless effort to defeat the Chinese virus," Trump said.
California Governor Gavin Newsom is projected to keep his job. Around two-thirds of the votes have been reported, and roughly 64% of those votes are in favor of keeping Newsom as their governor.
Daniel Strauss, senior political correspondent at The New Republic, joined Cheddar's Opening Bell to discuss more about what Newsom's win means to both political parties moving into Midterm elections season.
The Department of Justice is suing Texas over the state's new abortion law that prohibits abortions after six weeks, well before many women even know they're pregnant. The lawsuit argues the law is unconstitutional under long-standing Supreme Court precedent. It was filed last week in federal court in Texas, but could go all the way to the high court within weeks. Josh Blackman, a constitutional law professor at South Texas College of Law Houston, discusses the DOJ lawsuit and what it could mean for other abortion laws across the country.
26 states have now fully vaccinated more than half of their population with Vermont, Connecticut, and Massachusetts fully vaccinating at least two-thirds of their residents. These three states are among the ones with the lowest new Covid-19 cases per capita, but in states with low vaccination rates, hospitals are filling up again.
Dr. Rob Davidson, ER doctor and executive director of Committee to Protect Health Care, joined Cheddar's Opening Bell to discuss more.
The Biden Administration has officially extended a ban on a Trump-era policy that prohibits traveling with a U.S. passport to North Korea. The extension is expected to last until August 2022. The ban was initially enforced after the death of Otto Warmbier, who entered a vegetative state while in North Korean custody. Advocates against the ban argue that it has caused crippling impacts on Korean Americans who have not been able to reunite with their families back home. Senior Fellow at The Foundation For Defense of Democracies Anthony Ruggiero joined Cheddar's News Wrap to discuss more.
